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Key messages

-   This small-sample exploratory study suggests that primary care-based home telemonitoring of complex chronic patients may be a promising technology that which might reduce hospital admissions and the length of hospital stays.

-   Moreover, this study suggests a reduction of the number of emergency department attendances while patients were telemonitored.

Introduction {#s0001}
============

The growing prevalence of chronic health problems and the pressing need for efficient healthcare resources are encouraging the adoption of new effective primary care models. Among such models, home telemonitoring of patients with chronic diseases could offer a possible solution. The telemonitoring of patients in a home setting involves the remote transmission of patient clinical data, allowing subsequent examination by healthcare professionals. Such flow of frequent clinical information may facilitate the patient follow-up and enables decision making which in turn, could lead to faster interventions and avoidance of hospital admissions and use of other healthcare resources. This approach has been most widely applied in heart failure (HF) and chronic obstructive pulmonary disease (COPD).

Several randomized controlled trials (RCT) and systematic reviews with or without meta-analyses \[[@CIT0001]\] have been recently published regarding the utility of telemonitoring in reducing hospital admissions and mortality \[[@CIT0001],[@CIT0002],[@CIT0004],[@CIT0008],[@CIT0009]\] in HF, and in decreasing admissions in COPD patients \[[@CIT0007],[@CIT0010]\]. The effect in emergency department attendances has been less explored or there is less evidence regarding this outcome measure. Among the randomized clinical trials, the 'whole system demonstrator' (WSD) deserves a special mention, because of its size (3230 patients with diabetes, COPD or HF were included), its practical nature (179 primary care centres were involved) and the impact on mortality, number of emergency department attendances, and number of hospital admissions, showing reductions of 45%, 20% and 11%, respectively \[[@CIT0011],[@CIT0012]\]. However, the telemonitoring experiences managed from primary care are still scarce \[[@CIT0013]\], despite the fact that chronic patients can receive routine care through this level of assistance and implementation of such technology in primary care has been associated with higher efficiency and lower costs compared to the hospital level \[[@CIT0014],[@CIT0015]\].

In the previous TELBIL RCT \[[@CIT0014],[@CIT0016]\], the assessment of a primary care-based telemonitoring intervention showed a significant decrease in healthcare resources use \[[@CIT0014]\]. In 2012, the TELBIL-A study was launched, consisting of an implementation of the previous strategy and further evaluation of the adapted telemonitoring intervention. Marked changes were made seeking to improve the benefits of the remote monitoring and, at the same time, fully integrating the process within actual clinical primary care practice. A high level of acceptance and satisfaction with the TELBIL-A intervention was observed among both patients/relatives and healthcare professionals \[[@CIT0017],[@CIT0018]\].

The objective of the present exploratory study was to assess the influence of a primary care-based home telemonitoring intervention for highly unstable (complex) chronic patients, within routine clinical practice, on healthcare resource use (i.e. hospital admissions and emergency department attendances).

Methods {#s0002}
=======

Study design and setting {#s0003}
------------------------

We used a comparative before and after exploratory study, without a control group. The overall length of the study (open recruitment of patients during the first year) was from mid-February 2012 to mid-February 2014, with an individual follow-up per patient of one year, from the inclusion date up to the following year. [Figure 1](#F0001){ref-type="fig"} summarizes the general project design.

![Study design and flow of participants through the study. IG: intervention group; RCT: randomized controlled trial; HF: heart failure; CLD: chronic lung disease; GP: General Practitioner.](igen_a_1306516_f0001_b){#F0001}

The study was conducted in the urban-based Bilbao-Basurto Integrated Healthcare Organization (IHO), with a catchment population of around 384 000 people. This IHO included a referral hospital and 25 primary healthcare centres (PHC), with 230 general practitioners (GPs) and 320 nurses.

The study was approved by the Ethics Committee for Scientific Research (Basurto University Hospital, Bizkaia) (19 October 2011) and the Primary Care Research Committee of the Basque Health Service (Osakidetza) (18 October 2011). Patients/relatives gave written informed consent prior to participating in the study.

Selection of study patients {#s0004}
---------------------------

*Inclusion criteria.* Adult housebound patients (with great difficulty or inability to leave their home) with HF and/or chronic lung disease (CLD) (mainly COPD and a few of them with asthma), with a history of at least two hospital admissions in the previous year (and at least one of them due to the aforementioned conditions) were included in the study. These were also the patient inclusion criteria in the TELBIL RCT.

For newly included patients, those who as well as having HF and/or CLD, had markedly impaired functional status (Barthel index \<60) due to concomitant chronic conditions and had two hospital admissions in the previous year or, alternatively, had several emergency department attendances or hospital admissions in recent years could also be included in the study.

Owing to the specific inclusion conditions and complexity of the patients, and based on previous records and lists used in the TELBIL RCT, we estimated that there would be approximately 80 eligible patients in the Bilbao-Basurto IHO. According to the ambulatory care group-predictive modelling (ACG-PM) stratification \[[@CIT0019]\], 27.6% of patients included in our study were labelled as 'complex patients' coinciding with the tip of the Kaiser Permanente pyramid. The majority of them, however, were above the aforementioned level, giving an indication of the high complexity and instability of the sample studied.

Exclusion criteria {#s0005}
------------------

Patients in residential care, those in terminal phases with a life expectancy of less than six months due to other illnesses unrelated to the inclusion condition (as subjectively judged by their GPs), and those unable to carry out a continuous follow-up using the telemonitoring equipment were excluded.

Patient recruitment process {#s0006}
---------------------------

First, patients belonging to the intervention and control groups of the preceding TELBIL RCT, who wished to continue or start the telemonitoring were recruited. Second, new patients were recruited by nurses and GPs that agreed to participate in the study, once the project was presented at all PHC and collaboration was requested. Additionally, recruitment was conducted by the advanced practice nurses (APN, nurses who specialize in the care of patients with multimorbidity at home). Participants gradually joined the study over a period of one year. Influenced by budget and time limitations, all potentially eligible patients could not be included in the study.

Intervention {#s0007}
------------

The telemonitoring consisted of daily self-monitoring of a patient-specific set of clinical parameters, sent from the patient's home using smartphones to a specific Web-platform. Additionally, patients/caregivers completed a brief health status questionnaire assessing the patient's perception of his/her medical and functional condition, together with a series of common and condition-specific questions. The contents of the questionnaire were personalized based on the patient's clinical characteristics, specific pathology and the criterion of the GP or nurse in charge of the patient. [Table 1](#t0001){ref-type="table"} illustrates the default clinical parameters for the patients. When pre-established threshold values were crossed, red or yellow alerts were triggered at the web-platform where the data were transmitted daily.

###### 

Parameters and initial thresholds.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Parameter                                                                                                                                                                            Thresholds                                  Observations
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------- ----------------------------------------------------------
  Systolic blood pressure (SBP)                                                                                                                                                        100/150 mmHg                                for HF patients

  Diastolic blood pressure (DBP)                                                                                                                                                       50/90 mmHg                                  for HF patients

  Oxygen saturation (O~2~ sat)                                                                                                                                                         \<94% for HF patients\                      for all patients
                                                                                                                                                                                       \<93% for CLD patients with or without HF   

  Heart-rate                                                                                                                                                                           50/90 bpm                                   for all patients

  Respiratory-rate                                                                                                                                                                     12/26 breaths/min.                          for all patients

  Weight gain                                                                                                                                                                          \>1 kg/48 h.                                for HF patients

  ***Questionnaire***                                                                                                                                                                                                               

  Compared to yesterday, do you feel the same, better or worse?                                                                                                                        worse                                       for all patients

  Compared to yesterday, do you breathe similarly/better/worse?                                                                                                                        worse                                       for all patients

  Have you taken all your medicines?                                                                                                                                                                                               for all patients

  Do you follow an appropriate and low salt diet?                                                                                                                                                                                  for all patients

  Is the swelling of your ankles the same as before,has it decreased or increased?                                                                                                     higher                                      for HF patients

  Do you get up more often at night to urinate?Yes/no                                                                                                                                  yes                                         for HF patients;not applicable if usingincontinence pads

  Compared to yesterday, do you cough more often?Yes/no                                                                                                                                yes                                         for CLD patients

  Compared to yesterday, do you have moreexpectoration? Yes/no                                                                                                                         yes                                         for CLD patients

  Compared to yesterday, is the colour of your sputum more greenish/yellowish? Yes/no                                                                                                  yes                                         for CLD patients

  **Lack of transmission in seven days with no hospital admission or other justified cause**                                                                                                                                       generates an alert

  ***Alert levels***[\                                                                                                                                                                                                             
  ]{.ul}***Red alert***\                                                                                                                                                                                                           
  Oxygen saturation or heart-rate for HF and CLD patients.\                                                                                                                                                                        
  Weight gain or DBP for HF patients.\                                                                                                                                                                                             
  Increased cough or expectoration for CLD patients.\                                                                                                                                                                              
  A worsening of the functional and clinical status (questionnaire) together with an alert related to any of the clinical parameters.\                                                                                             
  The red alerts generated during the weekend activate the following message on the smartphone: 'remember that if your condition worsens, you should contact the emergency service'\                                               
  **Yellow alert**: the remaining alerts.                                                                                                                                                                                          
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HF: heart failure; CLD: chronic lung disease (COPD, asthma); DBP: diastolic blood pressure.

Study variables {#s0008}
---------------

The sociodemographic and clinical baseline information is shown in [Table 2](#t0002){ref-type="table"}. The main outcome measure was the number of hospital admissions that occurred during the 12 months before and after the inclusion of each patient in the study. Secondary outcome measures were the length of hospital stay per admission and the total number of emergency department attendances during the year of follow-up compared to the 12-months prior to telemonitoring. The information required for the analysis was obtained from electronic clinical records and discharge clinical reports.

###### 

Patients' baseline characteristics.

                                                                                        Total (*n* = 42)   Patients of the IGof TELBIL RCT(*n* = 15)   Newly recruitedpatients(*n* = 27)   *P*-value
  ------------------------------------------------------------------------------------- ------------------ ------------------------------------------- ----------------------------------- -----------
  **Sociodemographic variables**                                                                                                                                                            
  Gender                                                                                                                                                                                   0.853
   Male, *n* (%)                                                                        19 (45.3%)         6 (40%)                                     13 (48.2%)                           
   Female, *n* (%)                                                                      23 (54.7%)         9 (60%)                                     14 (51.8%)                           
  Age, mean (SD)                                                                        78.9 (7.5)         80.5 (6.8)                                  77.9 (7.8)                          0.103
  Living with                                                                                                                                                                              0.654
   Alone, *n* (%)                                                                       6 (14.3%)          2 (13.3%)                                   4 (14.8%)                            
   Spouse/partner, *n* (%)                                                              17 (40.5%)         7 (46.7%)                                   10 (37%)                             
   Other relative, *n* (%)                                                              12 (28.6%)         5 (33.3%)                                   7 (26%)                              
   Others, *n* (%)                                                                      7 (16.6%)          1 (6.7%)                                    6 (22.2%)                            
  Caregiver                                                                                                                                                                                0.097
   Spouse/partner, *n* (%)                                                              15 (35.7%)         6 (40%)                                     9 (33.3%)                            
   Daughter, *n* (%)                                                                    14 (33.3%)         7 (46.7%)                                   7 (26%)                              
   Son, *n* (%)                                                                         8 (20%)            0 (0%)                                      8 (29.6%)                            
   Other relative, *n* (%)                                                              4 (9.5%)           2 (13.3%)                                   2 (7.4%)                             
   Others, *n* (%)                                                                      1 (2.4%)           0 (0%)                                      1 (3.7%)                             
  **Clinical and functional variables**                                                                                                                                                     
  Disease for inclusion                                                                                                                                                                    0.922
   Heart failure, *n* (%)                                                               6 (14.3%)          3 (20%)                                     3 (11.1%)                            
   Chronic lung disease, *n* (%)                                                        10 (23.8%)         3 (20%)                                     7 (25.9%)                            
   Both, *n* (%)                                                                        24 (57.1%)         9 (60%)                                     15 (55.6%)                           
  Another condition with CLD and Barthel \<60                                           1 (2.4%)           0 (0%)                                      1 (3.7%)                             
  Another condition with HF and Barthel \<60                                            1 (2.4%)           0 (0%)                                      1 (3.7%)                             
  Barthel index score, mean (SD)                                                        68.3 (32)          72 (27.9)                                   66.3 (34.3)                         0.843
  **Use of healthcare resources mean (SD)**                                                                                                                                                 
  Regularly taken medicines/day                                                         12.3 (3.9)         11.5 (2.5)                                  12.8 (4.4)                          0.299
  All-cause hospital admissions/patient/year                                            2.6 (1.5)          3.1 (1.4)                                   2.4 (1.5)                           0.108
  Condition-specific[^a^](#TF3){ref-type="table-fn"} hospital admissions/patient/year   2 (1.2)            2.2 (0.9)                                   1.8 (1.3)                           0.199
  Length of hospital stay (days)                                                        10.7 (5.2)         10.8 (5.8)                                  10.6 (5)                            0.807
  Emergency department attendances/patient/year                                         4.1 (2.3)          4.5 (2.1)                                   3.8 (2.4)                           0.288
  EDA not followed by hospital admission/patient/year                                   1.4 (1.7)          1.4 (1.7)                                   1.4 (1.7)                           0.989
  \% of EDA without hospital admission                                                  60/170 (35.3%)     21/67 (31.3%)                               39/103 (37.9%)                      0.481

IG: intervention group; RCT: randomized controlled trial; SD: standard deviation; EDA: emergency department attendances;

Hospital admissions caused by respiratory, heart-related or another inclusion condition problems.

Sample size and power estimation {#s0009}
--------------------------------

A power estimation was calculated considering the 42 patients recruited for the study (constrained by budget and time limitations), using the results obtained in the preceding intervention group (IG) of the TELBIL study \[[@CIT0014]\]. A 25% loss to follow-up was assumed after 12 months, together with a mean of 3.4 all-cause hospital admissions in the year prior to telemonitoring and a standard deviation (SD) of 2.3 in the difference between the before and after rates. Based on these data, the study was estimated to have an 86% statistical power for detecting a 35% decrease in the number of all-cause admissions during the year of follow-up as statistically significant (95% confidence).

Data analysis {#s0010}
-------------

Patient's *baseline characteristics* were defined as those registered at the end of the telemonitoring-free period. Hence, the baseline values of participants coming from the IG of the TELBIL RCT corresponded to the measurements taken at the beginning of that study. Patients' baseline characteristics were described using means and SD or frequencies according to the quantitative or qualitative nature of the variables.

Homogeneity between patients lost to follow-up and patients completing the study was analysed. When dealing with quantitative variables the *t*-test or the non-parametric Mann--Whitney test was performed depending on the fulfilment of the normality assumption. For qualitative variables, the chi-squared test or the Fisher's exact test was conducted. Homogeneity in baseline characteristics between patients belonging to the IG of the preceding TELBIL RCT and newly recruited patients was checked analogously. A 95% confidence level was established.

To assess the influence on healthcare resources use (total and condition-specific admissions, length of hospital stays and emergency department attendances) a before and after analysis was performed. *T*-test for paired samples was carried out when the normality assumption was met; otherwise, the Wilcoxon signed-rank test was used.

Results {#s0011}
=======

A total of 42 patients were enrolled, 15 of which belonged to the IG of the TELBIL RCT and 27 were newly recruited (two patients were included by the APN). Two patients, out of the 27 newly recruited participants, had a severely impaired functional status with a Barthel index \<60. These two patients had other chronic diseases on top of HF/CLD that caused a serious deterioration of their functional status: one had morbid obesity and HF and the other had had a stroke and COPD. Three patients from the IG of the TELBIL RCT were excluded (two refused to continue and one had advanced mental impairment). Twenty-eight patients completed the 12-month follow-up, 11 of them came from the preceding trial. Fourteen patients were lost to follow-up (13 died and one declined to continue). Out of the 13 deceased patients, five died of heart causes, five of respiratory causes and three as a result of other diseases.

Baseline characteristics {#s0012}
------------------------

[Table 2](#t0002){ref-type="table"} summarises patients' baseline characteristics, both overall and distinguishing between participants coming from the IG of the TELBIL RCT and those newly recruited. The mean age was 78.9 (SD 7.5) years and 57.8% were women; 14.3% of patients had HF and 23.8% CLD while 57.2% had both conditions concurrently.

No variable showed significant differences among patients lost to follow-up and patients who completed the study (data not shown). Homogeneity between participants coming from the IG of the preceding trial and newly recruited patients was satisfied for all baseline characteristics.

Impact on healthcare resources use {#s0013}
----------------------------------

The results of the before and after analysis are shown in [Table 3](#t0003){ref-type="table"}. Statistically significant reductions in all-cause and condition-specific hospital admissions and emergency department attendances were found. The mean length of hospital stay was decreased by 3.5 days, though statistical significance was not reached.

###### 

Results of the before and after analysis on healthcare resources use (*n* = 28 patients).

                                                                                                   Before           After           *P*-value
  ------------------------------------------------------------------------------------------------ ---------------- --------------- -----------
  All-cause hospital admissions, mean/patient/year (SD)                                            2.6 (1.6)        1.1 (1.5)       \<0.001
  Condition-specific hospital admissions[^a^](#TF4){ref-type="table-fn"}, mean/patient/year (SD)   1.9 (1.2)        0.6 (1.2)       \<0.001
  Length of hospital stay, mean/patient/year (SD)                                                  11.4 (6.9)       7.9 (3.3)       0.074
  Emergency department attendances, mean/patient/year (SD)                                         4.2 (2.6)        2.11 (2.6)      \<0.001
  Emergency department attendances not followed by hospital admissions, mean/patient/year (SD)     1.7 (1.9)        1 (1.4)         0.034
  Proportion of emergency department attendances not followed by hospital admission                60/170 (35.3%)   29/59 (49.1%)   0.084

Hospital admissions caused by respiratory or heart-related exacerbations.

SD: standard deviation.

Considering the specific pathologies, when both (CLD and HF) coexisted in the same patient who completed the year of follow-up (*n* = 16), there were significant differences in all-causes of hospital admissions, mean 2.8 (SD: 1.5) versus 1.1 (SD: 1.8) (*P* = 0.017), and in the emergency department attendances not followed by hospital admissions, 2.3 (SD: 2.1) versus 0.9 (SD: 1.4) (*P* = 0.009); but not in condition-specific hospital admissions (*P* = 0.091). Only a very small number of patients had one of the two pathologies exclusively (eight patients had CLD and four had HF).

Discussion {#s0014}
==========

Main findings {#s0015}
-------------

*Hospital admissions.* The results of this small exploratory study appear to show that the impact of the intervention on the reduction of hospital admissions and emergency department attendances seemed to be greater than in the previous TELBIL RCT \[[@CIT0014]\], probably due to the positive influence of the modifications made to the intervention. The before and after analysis, showed a statistically significant decrease in the number of hospital admissions during the 12-month telemonitoring period compared to the previous year. This finding is in agreement with other studies \[[@CIT0003],[@CIT0006],[@CIT0012],[@CIT0020]\].

*Emergency department attendances*. Moreover, a significant decrease in the number of emergency department attendances was observed. Specifically, the mean number of total attendances fell from 4.2 in the 12-month period before telemonitoring to 2.1 during the 12-month follow-up. A similar decrease was also noted in other studies, such as the WSD project, which reported a 20% reduction \[[@CIT0012]\], although there is considerably less published evidence regarding this outcome measure. Nevertheless, the percentage of emergency department attendances without subsequent hospital admissions increased, which could be a positive indicator, since a higher percentage of emergency department attendances could have been solved without the need for admission.

*Length of hospital stay*. A notable reduction of length of the hospital stays was noticed, which, despite not being statistically significant, was consistent with other telemonitoring studies of patients with HF or COPD \[[@CIT0002],[@CIT0012],[@CIT0013]\]. In the present study, the mean length of stay decreased by 3.5 days after telemonitoring, which could have had a substantial impact both on the quality of life of the patients/relatives and on the costs associated with hospitalization. Such a reduction of hospital stay could be due to the early detection and treatment of exacerbating factors.

*Satisfaction of professionals and patients*. In addition to the positive impact on the use of healthcare resources, the high level of satisfaction of the healthcare professionals and patients/relatives with the telemonitoring in the TELBIL-A study constitutes a key factor that may influence the successful uptake of such interventions \[[@CIT0017],[@CIT0018]\]. Other studies have also shown that healthcare professionals are generally satisfied with telemedicine activities when they are closely involved \[[@CIT0021]\], although results are not consistent \[[@CIT0024],[@CIT0025]\].

Strengths and limitations {#s0016}
-------------------------

Unlike the preceding TELBIL study, a RCT focused on efficacy, this study closely reflects the patient baseline conditions, since telemonitoring was integrated within regular clinical practice. We consider that the complexity of the patients included in the study (which had a high mortality as shown in our previous publications \[[@CIT0026]\]), focussing on the comorbidity and functionality more than on specific pathologies, and the control of telemonitoring by professionals who are usually in charge of these patients, are the main strengths of the TELBIL design.

The main limitations of the present study are those inherent to before and after study designs and the lack of a control group. Another important limitation is the fact that this was an exploratory study with a small sample size. Such limitations should be taken into account when interpreting the impact observed on healthcare resources use.

We included patients coming from the preceding TELBIL RCT, monitored for 2.5 years on average previously, which could bias the results. Nevertheless, the statistical analysis applied considering the events at baseline in patients coming from the TELBIL RCT, the homogeneity analysis at baseline and the subgroup analysis carried out, counteracted this influence showing that the possible bias introduced was not substantial.

Implications for clinical practice {#s0017}
----------------------------------

The present exploratory study appears to indicate the utility of a primary care-based telemonitoring intervention for complex chronic patients in reducing healthcare resources use.

Among the key factors for successful implementation of home-care telemonitoring in primary care, we highlight the positive acceptance and adherence to telemonitoring of the primary care professionals in charge of the patients, the promotion of the leading role of nursing, the institutional support for these kind of initiatives, the availability of human and material resources and the reorganization of care processes within a planned diffusion strategy. We believe that telemonitoring of complex chronic patients managed from primary care should be taken further, as the basic means to ensure coordination of the care of these patients across care levels.

Conclusion {#s0018}
==========

In the light of the findings of the present exploratory study, home telemonitoring of patients with HF or CLD implemented in real clinical practice and controlled from primary care seemed to have a positive impact on healthcare resources use, reducing both all-cause and condition-specific hospitalizations and emergency department attendances, and showing a decreasing trend for the length of hospital stay.
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